<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="478007" id="root" date="1997-04-01" xml:lang="en">
<title>USA: Genelabs says Phase III on schedule.</title>
<headline>Genelabs says Phase III on schedule.</headline>
<dateline>REDWOOD CITY, Calif 1997-04-01</dateline>
<text>
<p>Genelabs Technologies Inc said it remains on schedule to announce the results of its recently completed Phase III clinical trial for GL701 for lupus before the end of the second quarter.</p>
<p>The company has been working very closely and cooperatively with the Food and Drug Administration (FDA) to complete a final analysis plan. Subsequently, the company will commence analysis of this clinical data.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-01"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-01"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C23">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-01"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-01"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-04-01"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-04-01"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="REDWOOD CITY, Calif"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
